Agenus Correlations
| AGEN Stock | USD 1.73 0.05 2.81% |
The current 90-days correlation between Agenus Inc and Adaptimmune Therapeutics Plc is 0.25 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Agenus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Agenus Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Agenus Correlation With Market
Weak diversification
The correlation between Agenus Inc and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Agenus Inc and DJI in the same portfolio, assuming nothing else is changed.
Agenus |
Moving together with Agenus Stock
| 0.88 | A | Agilent Technologies | PairCorr |
| 0.84 | DNLI | Denali Therapeutics | PairCorr |
| 0.86 | VCEL | Vericel Corp Ord | PairCorr |
| 0.85 | VCYT | Veracyte | PairCorr |
| 0.66 | DRTS | Alpha Tau Medical | PairCorr |
Moving against Agenus Stock
| 0.65 | DVAX | Dynavax Technologies | PairCorr |
| 0.73 | VNDA | Vanda Pharmaceuticals | PairCorr |
| 0.36 | VRTX | Vertex Pharmaceuticals | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Agenus Stock performing well and Agenus Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Agenus' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ICVX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| GRTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MRKR | 5.89 | (1.32) | 0.00 | (1.73) | 0.00 | 8.29 | 49.05 | |||
| EWTX | 2.88 | 0.06 | 0.00 | (0.05) | 0.00 | 5.32 | 26.44 | |||
| ADAP | 2.59 | (0.32) | 0.00 | (0.47) | 0.00 | 4.84 | 21.59 | |||
| MREO | 2.57 | (0.51) | 0.00 | (0.81) | 0.00 | 6.16 | 20.77 | |||
| PIRS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| PDSB | 4.66 | (0.39) | 0.00 | (0.57) | 0.00 | 9.21 | 33.91 | |||
| LPTX | 4.89 | (2.16) | 0.00 | 372.80 | 0.00 | 5.18 | 82.92 | |||
| VKTX | 3.64 | (0.55) | 0.00 | (1.00) | 0.00 | 8.39 | 24.65 |
Agenus Corporate Management
| Julie DeSander | Chief Officer | Profile | |
| Alfred Dadson | Chief Officer | Profile | |
| Eric Humes | Chief Officer | Profile | |
| Regina Grebla | VP Communications | Profile | |
| Dr MBA | Chief Officer | Profile | |
| John Castle | Head Bioinformatics | Profile | |
| Zack Armen | Head Development | Profile |